Page last updated: 2024-10-27

gabapentin and Dysautonomia

gabapentin has been researched along with Dysautonomia in 2 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Research Excerpts

ExcerptRelevanceReference
"Gabapentin is a reasonable first-line choice, and opioid medications can be added for more severe pain but there are few clinical trials to inform specific recommendations."2.52Headache and Pain in Guillain-Barré Syndrome. ( Farmakidis, C; Herskovitz, S; Inan, S; Milstein, M, 2015)
"Macroglossia has been reported in patients undergoing posterior fossa neurosurgical procedures and is thought to be as a result of venous engorgement from intubation or mechanical positioning during these prolonged procedures."1.40Macroglossia associated with brainstem injury. ( Ardelt, A; Cueva, W; Frank, J; Goldenberg, F; Iwuchukwu, I; Reshi, R, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwuchukwu, I1
Ardelt, A1
Cueva, W1
Reshi, R1
Goldenberg, F1
Frank, J1
Farmakidis, C1
Inan, S1
Milstein, M1
Herskovitz, S1

Reviews

1 review available for gabapentin and Dysautonomia

ArticleYear
Headache and Pain in Guillain-Barré Syndrome.
    Current pain and headache reports, 2015, Volume: 19, Issue:8

    Topics: Amines; Animals; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Guillain-Barre Sy

2015

Other Studies

1 other study available for gabapentin and Dysautonomia

ArticleYear
Macroglossia associated with brainstem injury.
    Neurocritical care, 2014, Volume: 20, Issue:1

    Topics: Adolescent; Adrenergic beta-Antagonists; Aged; Amines; Anti-Inflammatory Agents; Brain Injuries; Bra

2014